Standard Biotools Inc (LAB) — Net Asset Quality Index
Standard Biotools Inc (LAB) has a Net Asset Quality Index of 87.8% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $639.11 Million minus total liabilities of $77.99 Million yields net assets of $561.12 Million. A higher index indicates a stronger, lower-leverage balance sheet. See LAB days of operational coverage to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Standard Biotools Inc Net Asset Quality Index Over Time (2006–2025)
This chart shows how Standard Biotools Inc's Net Asset Quality Index has evolved across 20 annual periods from 2006 to 2025. As of March 2026, the index stands at 87.8%, representing net assets of $561.12 Million against total assets of $639.11 Million USD. Explore how efficiently does Standard Biotools Inc generate cash to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Standard Biotools Inc (2006–2025)
The table below presents the year-by-year Net Asset Quality Index for Standard Biotools Inc from 2006 to 2025, covering 20 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see LAB stock market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 74.7% | $424.29 Million | $567.75 Million | $143.46 Million | ▼ -2.3 pp |
| 2024 | 77.0% | $471.72 Million | $612.34 Million | $140.62 Million | ▲ +122.9 pp |
| 2023 | -45.8% | $-148.05 Million | $323.07 Million | $471.12 Million | ▼ -25.0 pp |
| 2022 | -20.9% | $-81.47 Million | $390.31 Million | $471.78 Million | ▼ -55.2 pp |
| 2021 | 34.4% | $94.60 Million | $275.21 Million | $180.62 Million | ▼ -8.4 pp |
| 2020 | 42.8% | $139.05 Million | $324.76 Million | $185.71 Million | ▼ -15.2 pp |
| 2019 | 58.0% | $153.61 Million | $264.81 Million | $111.20 Million | ▲ +34.3 pp |
| 2018 | 23.7% | $72.12 Million | $303.65 Million | $231.53 Million | ▲ +13.0 pp |
| 2017 | 10.8% | $30.93 Million | $287.35 Million | $256.42 Million | ▼ -6.6 pp |
| 2016 | 17.4% | $53.23 Million | $306.39 Million | $253.16 Million | ▼ -13.6 pp |
| 2015 | 31.0% | $114.90 Million | $371.06 Million | $256.16 Million | ▼ -5.9 pp |
| 2014 | 36.9% | $150.42 Million | $407.56 Million | $257.14 Million | ▼ -46.2 pp |
| 2013 | 83.1% | $97.12 Million | $116.92 Million | $19.80 Million | ▼ -5.4 pp |
| 2012 | 88.5% | $100.66 Million | $113.73 Million | $13.07 Million | ▲ +16.8 pp |
| 2011 | 71.7% | $56.90 Million | $79.33 Million | $22.43 Million | ▲ +834.5 pp |
| 2010 | -762.7% | $-189.17 Million | $24.80 Million | $213.97 Million | ▼ -222.8 pp |
| 2009 | -540.0% | $-173.62 Million | $32.15 Million | $205.77 Million | ▼ -50.6 pp |
| 2008 | -489.4% | $-158.34 Million | $32.35 Million | $190.69 Million | ▼ -251.5 pp |
| 2007 | -237.9% | $-130.33 Million | $54.78 Million | $185.11 Million | ▲ +53.0 pp |
| 2006 | -290.9% | $-106.17 Million | $36.49 Million | $142.66 Million | — |